Ali Khademhosseini is the Levi Knight Professor of Bioengineering, Chemical Engineering and Radiology at the Univeristy of California-Los Angeles (UCLA). He is the Founding Director of the Center for Minimally Invasive Therapeutics at UCLA. In addition, he is an eminent scholar at Konkuk University in Korea.
He joined UCLA starting Nov. 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials.
He is a leader in applying bioengineering solutions to precision medicine. His large and interdisciplinary group is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. In enabling this vision, he works closely with clinicians (including interventional radiologists, cardiologists and surgeons). For example, he has developed numerous techniques in controlling the behavior of patient-derived cells to engineer artificial tissues and cell-based therapies. He is also developing ‘organ-on-a-chip’ systems that aim to mimic human physiology and pathology to enable patient-specific evaluation of drug candidates. In addition, his laboratory is a leader in utilizing biofabrication to form vascularized tissues with appropriate microarchitectures as well as regulating stem cell differentiation in microengineered environments. He has also pioneered various high-performance biomaterials that can respond to each patient’s needs. He has edited multiple books / journal special issues and is an author on >500 peer-reviewed journal articles, editorials and review papers, >60 book chapters/edited books and >20 patent/disclosure applications. His work has been published in leading journals and routinely highlighted in international media. He has been cited >44,000 times and has an H-index of 109. Also, he has given over >250 invited seminars and keynote lectures. Annually for the past four years he has been selected by Thomson Reuters as one of the World’s Most Influential Minds as a Highly Cited Researcher.